Q3 2025 Stepan Co Earnings Call Transcript
Key Points
- Stepan Co (SCL) reported a 9% growth in adjusted EBITDA for the first nine months of 2025, reaching $165 million.
- The specialty products segment saw significant growth, with adjusted EBITDA increasing by 113% due to favorable order timing in the pharmaceutical business.
- Total company sales volumes grew by 1%, with polymers up 8% and the NCT product line up 26%.
- Free cash flow was positive at $40 million during the quarter, driven by reduced working capital and disciplined capital spending.
- Stepan Co (SCL) has paid and increased dividends for 58 consecutive years, with a recent 2.6% increase in the quarterly cash dividend.
- Adjusted net income for the third quarter of 2025 was $10.9 million, down 54% compared to the prior year.
- The company faced significant increases in oleochemicals raw material prices, impacting margins.
- Higher startup costs related to the new Pasadena, Texas facility affected financial performance.
- The surfactants segment experienced a 2% decline in sales volume due to lower demand in global commodity consumer products.
- The polymer segment saw a 4% decrease in net sales, primarily due to lower selling prices and competitive pressures.
Good morning and welcome to the Stepan Company Third quarter 2025 earnings conference call.
(Operator Instructions)
It is now my pleasure to turn the call over to Mr. Ruben Velasquez, Vice President and Chief Financial Officer of Stepan Company Mr. Velasquez, please go ahead.
That's Jacinda. Good morning and thank you for joining Stepan's Company third quarter 2025 Financial Review. Before we begin, please note that information in this conference call contains forward-looking statements which are not historical facts.
These statements involve risks and uncertainties that could cause actual results to differ material, including but not limited to prospects for our foreign operations, global and regional economic conditions, and factors detailed in our Securities and Exchange Commission filings.
In addition, this conference call will include discussions of adjusted net income, adjusted EBITDA, and free cash flow, which are non-GAAP measures. We provide
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
